Comunicazioni orali selezionate

Di seguito riportiamo l’elenco delle Comunicazioni Orali selezionate che saranno presentate a Roma. Tutti i poster inviati sono stati accettati per il Final Contest, la prossima settimana ne pubblicheremo l’elenco dettagliato.

L’ordine di presentazione delle singole relazioni a cura degli Autori sarà quanto prima comunicata con la pubblicazione del programma finale dell’evento previsto per le giornate del 29 e 30 settembre a Roma.


  ANTONELLI Alberto |Firenze  First detection of a multiresistance transposon of original structure harbouring cfr gene and a novel putative efflux pump in a linezolid-resistant MRSA

 BAI Francesca | Milano  Factors associated with anal/cervical HPV infection and dysplasia in a cohort of HIV-infected male and female patients

 BARTOLETTI Michele | Bologna  Bloodstream infection in cirrhotic patients: a prospective multicenter study (Bichrome)

 BERTOLDI Alessia | Bologna  Longitudinal evaluation of reservoir size decay in naïve HIV patients starting ART

 BOGLIONE Lucio | Torino   Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors

 BOZZI Giorgio | Milano  No Evidence of Ongoing Replication in Tissue Compartments During Combination Antiretroviral Therapy

 CANNIZZO Stefania E. | Milano  Role of microbial translocation in HIV infected patients during suppressive Antiretroviral Therapy (cART) and causal relationship with HIV-driven bone impairment

 CENTO Valeria | Roma  High efficacy of HCV resistance-guided retreatment strategies after protease inhibitors failure in real-life settings

 CORCIONE Silvia| Torino  Antimicrobial Stewardship in a Long Term Acute Care Hospital Using Offsite Electronic Medical Record Audit

 D’ABRAMO Alessandra | Roma  Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients

 DE PASCALIS Stefania | Napoli  ITPase activity modulates the severity of anemia in patients with hcv-related cirrhosis treated with ribavirin-containing IFN-free regimens

 DE ROSA Annalisa | Roma  Extensively drug resistant Pseudomonas aeruginosa: a study on carbapenem resistance mechanisms

 DEL PUENTE Filippo | Genova   Bone status evaluation by QUS in patients perinatally infected with HIV-1. A longitudinal study from childhood to early adult age

 DI CRISTO Valentina | Milano  Factors involved in continuance of atazanavir-based regimens : results from a cohort of HIV1-positive patients

 DI GENNARO Francesco | Bari   The sound of TB: role of lung ultrasound in the diagnosis and follow-up of pulmonary tuberculosis in resource limited settings

 FOCA’ Emanuele | Brescia    Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV co-infected patients with detectable HCV RNA. A MASTER Cohort study

 GIACOBBE Daniele Roberto | Genova   Lower sensitivity of serum (1,3)-beta-D-glucan for the diagnosis of candidemia due to Candida parapsilosis

 GIROMETTI Nicolò | Bologna   Outcomes of acutely HIV-1 infected individuals following rapid antiretroviral therapy initiation.

 IANNETTA Marco | Roma   Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation

 LAGI Filippo | Firenze   Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults

 MACERA Margherita | Napoli   CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection

 MALAGNINO Vincenzo | Roma  Emerging genotype E of Hepatitis B Virus in Young African migrants in Rome: new clinical and virological settings

 MAZZANTI Sara | Ancona   Epidemiologia, caratteristiche cliniche e mortalità della candidemia nell’età avanzata

 MAZZITELLI Maria | Catanzaro    Studio CARDIAC: (CARdiac DIseases in Antiviral therapy for HCV). Valutazione della funzionalità cardiaca in pazienti con infezione da HCV in trattamento con nuovi DAA

 MENOZZI Marianna | Modena   CD4/CD8 ratio matters to age related health outcomes in HIV infected patients with comorbidities, frailty and disability.

 MERLINI Esther | Milano    Association Between Mucosal-Associated Invariant T (MAIT) Cells and Gut Microbiome: Friend or Foe in Chronic Viral Infections?

 MUSUMECI Giuseppina | Bologna   M48U1 and Tenofovir combination synergistically inhibits HIV-1 infection in activated PBMCs and human cervicovaginal histocultures

 ONORATO Lorenzo | Napoli   Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study

 PASCALE  Renato | Bologna    Tigecycline, an ecological choice? Retrospective cohort study of colonization or infection risk with Carbapenems-Resistant Klebsiella pneumoniae or Clostridium difficile following antibiotic treatment of intra-abdominal infection

 RINALDI Francesca | Pavia   Medical treatment versus “Watch and Wait” in the clinical management of CE3b echinococcal cysts of the liver

 RONZI Paola | Milano   Attività e tossicità in vitro dei composti peptidomimetici biciclici come inibitori della proteasi di HIV-1

 RUGGIERO Alessandra | Liverpool   During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ

 SALADINI Francesco | Siena  Preliminary evaluation of antiviral activity of candidate HIV inhibitors targeting human DDX3 protein

 SATTA Giovanni | Londra   Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance

 STRAZZULLA Alessio | Catanzaro    Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

 SVICHER Valentina | Roma   Identification and Characterization of Specific Genetic Elements in HBV Surface Glycoprotein correlated with Hepatocellular Carcinoma: An In Vivo and In Vitro Analysis

 TURRINI Filippo | Milano   The HIV-1 Transcriptional Repressor TRIM22 Is a Novel Determinant of Proviral Latency and Disease Progression

 VELOCI Sara | Firenze   HBV in gravidanza: analisi di una popolazione di 213 gestanti e valutazione dell’outcome dei nati da donne con elevata viremia presso l’Azienda Ospedaliero Universitaria Careggi, Firenze.

 VENANZI-RULLO Emmanuele | Messina    Amfotericina in aerosol per il trattamento dell’aspergillosi polmonare invasiva, uno studio di coorte retrospettivo osservazionale”

 ZAMMARCHI Lorenzo | Firenze    A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries


Anna Scotti
No Comments

Sorry, the comment form is closed at this time.